SEC Form 4 · accession 0001209191-15-035040
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Sblendorio
Director
Period of report
Apr 15, 2015
Accepted (ET)
Apr 17, 2015 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Apr 15, 2015 | M | 20,000 | $12.50 | A | 31,933 | D | |
| Common stock | Apr 15, 2015 | S | 20,000 | $12.50 | D | 11,933 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $7.51 | Apr 15, 2015 | M | 10,000 | D | Jun 13, 2012 | May 24, 2021 | Common Stock | 10,000 | 0 | D |
| Stock Options (right to buy) | $7.15 | Apr 15, 2015 | M | 10,000 | D | Jun 15, 2010 | Jun 10, 2019 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2014.